Contact
Privacy
DMCA
Robuta
https://c19early.org/admeta.html
Adintrevimab for COVID-19: real-time meta-analysis of 2 studies
2 adintrevimab COVID-19 controlled studies. 43% improvement, p = 0.48.
real time
meta analysis
adintrevimab
covid